The US Food and Drug Administration has approved a groundbreaking new drug for advanced pancreatic cancer, providing a new treatment option for patients suffering from one of the world’s deadliest cancers.
Ad Blocker Enabled!
Ad Blocker Enabled!
Our website is made possible by displaying online advertisements to our visitors. Please support us by disabling your Ad Blocker.